Research output per year
Research output per year
Search results
-
2016
MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma
de la Puente, P., Muz, B., Jin, A., Azab, F., Luderer, M., Salama, N. N. & Azab, A. K., 2016, In: Blood Cancer Journal. 6, 2, e399.Research output: Contribution to journal › Letter › peer-review
Open Access -
Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma
de la Puente, P., Quan, N., Hoo, R. S., Muz, B., Gilson, R. C., Luderer, M., King, J., Achilefu, S., Salama, N. N., Vij, R. & Azab, A. K., 2016, In: Haematologica. 101, 7, p. e307-e311Research output: Contribution to journal › Letter › peer-review
Open Access